A team led by Lueienne Chatenoud of Hopital Necker in Paris developed a different CD3-targeting monoclonal antibody that prevented diabetes in mice.
The researchers subsequently modified that monoclonal antibody into the experimental drug ChAglyCD3, which is safer for people.
Chapter 2 - Trends in cancer monoclonal antibody dealmaking
Bigpharma cancer monoclonal antibody dealmaking activity
2 Summarization of Global Monoclonal Antibody
We expect significant opportunities for further commercial growth from 2009 to 2024, as shown in our new report, Monoclonal Antibody
Table 2: Leading Players in the Worldwide Monoclonal Antibody
Therapy Market (2005): Percentage Breakdown of Sales for Genentech/Roche, J & J/Schering Plough, Abbott Laboratories, MedImmune, ImClone/BMS, and Eli Lilly (includes corresponding Graph/Chart) II-5
This report assesses the overall monoclonal antibody
market, as part of the wider protein therapeutics industry.
Seattle Genetics and its collaborators presented preclinical data on SGN-70, a humanized monoclonal antibody
that targets the CD70 antigen, which is expressed in many types of hematologic malignancies.
As the exclusive marketing and distribution partner for Rabies monoclonal antibody
, Akorn will receive 40% of the revenues from product sales in North America and 50% of the revenues from product sales in Central and South America.
The Future of Monoclonal Antibody
Therapeutics: Innovation in antibody engineering, key growth strategies and forecasts to 2011, is a unique report that combines up-to-date analysis of the current antibodies market with detailed insights into therapeutic, technology, discovery and drug delivery trends set to shape the market in the next 5 years and beyond.
XOMA has royalty interests in RAPTIVA(R) (efalizumab), a monoclonal antibody
product marketed worldwide (by Genentech, Inc.